Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Cozen

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Journal of Cellular Biochemistry. Supplement|January 1, 1995
Perspective on cervical cancer: why prevent?C P Morrow, W Cozen
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 1, 1992
Risk patterns of Hodgkin's disease in Los Angeles vary by cell typeW Cozen, J Katz, T M Mack
Journal of Internal Medicine|June 4, 2019
The role of HLA variation in lymphoma aetiology and survivalC Zhong, W Cozen, R Bolanos, et al.
Journal of the National Cancer Institute|May 3, 2001
Changing relationship between socioeconomic status and prostate cancer incidenceL Liu, W Cozen, L Bernstein, et al.
British Journal of Cancer|October 3, 1999
The risk of angiosarcoma following primary breast cancerW Cozen, L Bernstein, F Wang, et al.
Blood|January 24, 1998
Seroprevalence of Kaposi's sarcoma-associated herpes virus antibody in young adult Hodgkin's diseaseW Cozen, R Masood, T Mack, et al.
Cancer Causes & Control : CCC|March 10, 2000
Descriptive epidemiology of thyroid cancer in Los Angeles County, 1972-1995T Haselkorn, L Bernstein, S Preston-Martin, et al.
Twin Research : the Official Journal of the International Society for Twin Studies|October 23, 2001
Development and representativeness of a large population-based cohort of native Californian twinsM G Cockburn, A S Hamilton, J Zadnick, et al.
Leukemia Research|August 11, 2000
Decreased chronic lymphocytic leukemia incidence in Asians in Los Angeles CountyR P Gale, W Cozen, M T Goodman, et al.
Blood Cancer Journal|July 2, 2013
Patterns of second primary malignancy risk in multiple myeloma patients before and after the introduction of novel therapeuticsP Razavi, K A Rand, W Cozen, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Journal of Cellular Biochemistry. Supplement|January 1, 1995
Perspective on cervical cancer: why prevent?C P Morrow, W Cozen
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 1, 1992
Risk patterns of Hodgkin's disease in Los Angeles vary by cell typeW Cozen, J Katz, T M Mack
Journal of Internal Medicine|June 4, 2019
The role of HLA variation in lymphoma aetiology and survivalC Zhong, W Cozen, R Bolanos, et al.
Journal of the National Cancer Institute|May 3, 2001
Changing relationship between socioeconomic status and prostate cancer incidenceL Liu, W Cozen, L Bernstein, et al.
British Journal of Cancer|October 3, 1999
The risk of angiosarcoma following primary breast cancerW Cozen, L Bernstein, F Wang, et al.
Blood|January 24, 1998
Seroprevalence of Kaposi's sarcoma-associated herpes virus antibody in young adult Hodgkin's diseaseW Cozen, R Masood, T Mack, et al.
Cancer Causes & Control : CCC|March 10, 2000
Descriptive epidemiology of thyroid cancer in Los Angeles County, 1972-1995T Haselkorn, L Bernstein, S Preston-Martin, et al.
Twin Research : the Official Journal of the International Society for Twin Studies|October 23, 2001
Development and representativeness of a large population-based cohort of native Californian twinsM G Cockburn, A S Hamilton, J Zadnick, et al.
Leukemia Research|August 11, 2000
Decreased chronic lymphocytic leukemia incidence in Asians in Los Angeles CountyR P Gale, W Cozen, M T Goodman, et al.
Blood Cancer Journal|July 2, 2013
Patterns of second primary malignancy risk in multiple myeloma patients before and after the introduction of novel therapeuticsP Razavi, K A Rand, W Cozen, et al.
Pageof 3